Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 386-390

  Zarghami, N ^a,b   Giai, M ^c   Yu, H ^a,b   Roagna, R ^c   Ponzone, R ^c   Katsaros, D ^c   Sismondi, P ^c   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast cancer; Creatine kinase BB isoenzyme; Enzymes in cancer; Prognostic indicators; Steroid hormone receptors

Indexed keywords

CREATINE KINASE BB; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CYTOSOL; ENZYME IMMUNOASSAY; FEMALE; FLUOROMETRY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030027522     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.66     Document Type: Article

References (28)

1. ARENAS J, DIAZ AE, ALCAIDE MT, SANTOS I, MARTINEZ A AND CULEBRAS JM. (1989). Serum CK-BB as a tumour marker in patients with carcinoma confirmed histologically. Clin. Chim. Acta, 182, 183-194.
2. BACH F, BACK FW, PEDERSEN AG, LARSEN PM AND DOMBERNOWSKY P. (1989). Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Eur. J. Cancer Clin. Oncol., 25, 1703-1709.
3. BLOOM HJG AND RICHARDSON WW. (1957). Histological grading and prognosis in breast cancer. Br. J. Cancer, 11, 359-377.
4. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc(B)., 34, 187-202.
5. HOPTON DS, THOROGOOD J, CLAYDEN A AND MACKINNON D. (1989). Observer variation in histological grading of breast cancer. Eur. J. Surg. Oncol., 15, 21-23.
6. KADDURAH-DAOUK R, ILLIE JW, DAOUK GH, GREEN MR, KINGSTON R AND SCHIMMEL P. (1990). Induction of a cellular enzyme for enzyme metabolism by transforming domains of adenovirus Ela. Mol. Cell Biol., 10, 1476-1483.
7. KAPLAN EL AND MEIER P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
8. KAYE AM, HALLOWES R, COX S AND SLUYSER M. (1986). Hormone-responsive creatine kinase in normal and neoplastic mammary glands. Ann. NY Acad. Sci., 464, 218-230.
9. McGING PG, TEELING M, McCANN A, KYNE F AND CARNEY DN. (1990). Non-M CK - a practical measure of creatine kinase isoenzymes in cancer patients. Clin. Chim. Acta, 187, 309-316.
10. McGUIRE WL AND CLARK GM. (1992). Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N. Engl. J. Med., 326, 1756-1761.
11. MALNICK SD, SHAER A, SOREQ H AND KAYE AM. (1983). Estrogen-induced creatine kinase in the reproductive system of the immature female rat. Endocrinology, 113, 1901-1907.
12. MARTIN KJ, CHEN SF, CLARK GM, DEGEN D, WAJIMA M, VON HOFF DD AND KADDURAH-DAOUK R. (1994). Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J. Natl Cancer Inst., 86, 608-613.
13. MOSS DW AND HENDERSON AR. (1994). Enzymes. In Tietz Texbook of Clinical Chemistry, second edn, Burtis AC and Ashwood ER (eds) pp. 797-809. WB Saunders: Philadelphia.
14. NERI B, BARTALUCCIS, CATALIOTTI L, DISTANTE V, TOMMASI M AND CIAPINI A. (1988). Clinical utility of the combined use of plurime tumor markers in human breast cancer. Cancer Detect. Prev., 13, 115-121.
15. PENTECOST BT, MATTEISS L, DICKERMAN HW AND KUMAR SA. (1990). Estrogen regulation of creatine kinase-B in the rat uterus. Mol. Endocrinol., 4, 1000-1010.
16. REISS NA AND KAYE AM. (1981). Identification of the major component of the estrogen-induced protein of rat uterus as the BB isoenzyme of creatine kinase. J. Biol. Chem, 256, 5741-5749.
17. RUBERY ED, DORAN JF AND THOMPSON RT (1982). Brain-type creatine kinase BB as a potential tumor marker-serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies. Eur. J. Cancer Clin. Oncol., 18, 951-956.
18. SCAMBIA G, NATOLI V, BENEDETTI PANICI P, SICA G AND MANCUSO S. (1986a). Estrogen-responsive creatine kinase in human breast cancer cells. J. Cancer Res. Clin. Oncol., 112, 29-32.
19. SCAMBIA G, PANICI PB, SICA G, NATOLI V, CARUSO A AND MANCUSO S. (1986b). Creatine kinase activity and steroidal hormone receptors in primary breast cancer. Ann. NY Acad. Sci., 464, 511-513.
20. SCAMBIA G, SANTEUSANIO G, BENEDETTI PANICI P, IACOBELLI S AND MANCUSO S. (1988). Immunohistochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content. J. Cancer Res. Clin. Oncol., 114, 101-104.
21. SPIESSL B et al. (1989). TNM Atlas: Illustrated Guide to the TNM/ pTNM. Classification of Malignant Tumors, third edn. Springer: New York.
22. THOMPSON RJ, RUBERY ED AND JONES HM. (1980). Radioimmunoassay of serum creatine kinase-BB as a tumor marker in breast cancer. Lancet, 2, 673-675.
23. THORPHE SM. (1987). Steroid receptors in breast cancer: sources of interlaboratory variation in dextran-charcoal assay. Breast Cancer Res. Treat., 9, 175-189.
24. THORPHE SM, ROSE C, RASMUSSEN BB, KING WJ, DeSOMBRE ER, BLOUGH RM, MOURIDSEN HT, ROSSING N AND ANDERSEN K W. (1986). Steroid hormone receptors as prognostic indicators in primary breast cancer. Breast Cancer Res. Treat., 7, (suppl.) 91-98.
25. TSUNG SH. (1983). Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms. Clin. Chem., 29, 2040-2043.
26. WALKER MD AND KAYE AM. (1981). mRNA for the rat uterine estrogen-induced protein. Transplantation in vitro and regulation by estrogen. J. Biol. Chem., 256, 23-26.
27. WALLIMANN T, WYSS M, BRIDICZKA D, NICOLAY K AND EPPENBERGER HM. (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem. J., 281, 21-40.
28. ZARGHAMI N, YU H, DIAMANDIS EP AND SUTHERLAND DJA. (1995). Quantification of creatine kinase BB isoenzyme in tumor cytosol and serum with an ultrasensitive time-resolved immunofluorometric technique. Clin. Biochem., 28, 243-253.